Novartis Global Head, Patient Affairs and Policy
Novartis was created in 1996 through a merger of Ciba-Geigy and Sandoz. Novartis and its predecessor...
Experienced pharmaceutical executive with demonstrated leadership skills across global and US medical affairs, clinical development; external communications. Currently heading a global group within Chief Medical Office responsible for Patient Engagement in Development and ensuring our clinical development policies are patient focused.
Specialties: Patient Affairs, Clinical Development Policy, General Medical Affairs; Leadership; Clinical Development; Psychiatry; Neuroscience; External Medical Affairs (Conflict of interest, transparency and disclosure)
I commit to listening to what patients say about our ICF and their experience in trialsWork in progress
I commit to continuing to hear from and partner with patient groups to drive a more patient focused clinical trials processWork in progress